These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9182896)

  • 1. Combined immunodeficiency phenotype associated with inappropriate spontaneous and activation-induced apoptosis.
    Pignata C; Fiore M; Scotese I; Cosentini E; Sperandeo MP; Turco C; Petrella A; Notarangelo L; Venuta S
    Clin Exp Immunol; 1997 Jun; 108(3):484-9. PubMed ID: 9182896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients.
    Malacarne F; Benicchi T; Notarangelo LD; Mori L; Parolini S; Caimi L; Hershfield M; Notarangelo LD; Imberti L
    Eur J Immunol; 2005 Nov; 35(11):3376-86. PubMed ID: 16276484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death.
    Brugnoni D; Airò P; Pennacchio M; Carella G; Malagoli A; Ugazio AG; Porta F; Cattaneo R
    Bone Marrow Transplant; 1999 Mar; 23(5):451-7. PubMed ID: 10100558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
    O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
    Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
    Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
    J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
    Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
    Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Patel DD; Gooding ME; Parrott RE; Curtis KM; Haynes BF; Buckley RH
    N Engl J Med; 2000 May; 342(18):1325-32. PubMed ID: 10793165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal T-Cell Engraftment Interferes With Human Leukocyte Antigen Typing in Severe Combined Immunodeficiency.
    Liu C; Duffy B; Bednarski JJ; Calhoun C; Lay L; Rundblad B; Payton JE; Mohanakumar T
    Am J Clin Pathol; 2016 Feb; 145(2):251-7. PubMed ID: 26834123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
    Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.
    Gaspar HB; Parsley KL; Howe S; King D; Gilmour KC; Sinclair J; Brouns G; Schmidt M; Von Kalle C; Barington T; Jakobsen MA; Christensen HO; Al Ghonaium A; White HN; Smith JL; Levinsky RJ; Ali RR; Kinnon C; Thrasher AJ
    Lancet; 2004 Dec 18-31; 364(9452):2181-7. PubMed ID: 15610804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engrafted maternal T cells in human severe combined immunodeficiency: evidence for a TH2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable beta repertoire.
    Plebani A; Stringa M; Prigione I; Facchetti P; Ghiotto F; Airoldi I; Giacchino R; Cristina E; Porta F; Grossi CE; Pistoia V
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):131-4. PubMed ID: 9449515
    [No Abstract]   [Full Text] [Related]  

  • 17. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
    Bacchetta R; Bigler M; Touraine JL; Parkman R; Tovo PA; Abrams J; de Waal Malefyt R; de Vries JE; Roncarolo MG
    J Exp Med; 1994 Feb; 179(2):493-502. PubMed ID: 7905018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cell death of activated lymphocytes in Omenn's syndrome.
    Brugnoni D; Airò P; Facchetti F; Blanzuoli L; Ugazio AG; Cattaneo R; Notarangelo LD
    Eur J Immunol; 1997 Nov; 27(11):2765-73. PubMed ID: 9394797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.
    Reinherz EL; Geha R; Rappeport JM; Wilson M; Penta AC; Hussey RE; Fitzgerald KA; Daley JF; Levine H; Rosen FS; Schlossman SF
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6047-51. PubMed ID: 6764536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.